SYLLABUS


 * HHP621

HHP- 621 CARDIOVASCULAR PHARMACODYNAMICS**
 * (3 credits) SPRING 2009** ***CLASSES WILL MEET IN *HSC (Health Science Center) 221* __NOT IN DEMERLY__**


 * LECTURER** - **P. Gannon** (Office HS-232) **888-5974** (phone mail) or- **674-1766** (leave message)


 * E: Mail: cardiopharm@gmail.com; profgannon@aol.com**

= =
 * OFFICE HOURS** –by Appointment
 * LECTURE** – WED: 5:30-8:30 P.M.
 * Class handouts & ANGEL/Wiki documents (required reading) and /or ProfGannon. Wikispaces.com (required reading) & OPIE CHAPTERS (optional)**
 * OPTIONAL TEXT**: Drugs for the Heart ; 6th ed. ; Opie, Lionel H., Gersh, Bernard J


 * COURSE DESCRIPTION :** **The objective of this course is to provide a basic knowledge of cardiovascular/pulmonary drugs, in particular their pharmacodynamics.** **Areas covered will include the antianginal drugs, antihypertensive drugs, antiarryhthmic drugs, drugs used to treat congestive heart failure, antihyperlipidemic drugs, antithrombic and fibrinolytic drugs, as well as some of the newer interventional agents.** **The drug classes will be covered in the context of the following clinical disorders angina, arrythmias, edema, congestive heart failure, systemic hypertension, pulmonary hypertension, hypotension and myocardial infarction**.


 * __EVALUATION__**: : **Exams (25% each) 1 & 2 + FINAL EXAM (30%) and POWERPOINT PRESENTATION (20%). EXAMS (for the most part objective type questions (MC, Fill-ins) (Each exam will have a few shorter answer essays) written as per schedule on specific topics of lecture material. POWERPOINT PRESENTATION (WILL BE ASSIGNED TOPIC IN CLASS).** **Guidelines for this PRESENTATION to follow.**

to aid in organizing the course materials. Students enrolled in this course will have access to this site. For those of you unfamiliar with WIKIS, I will prempt at first class. There will be a **__LINK__** to the wiki page via **ANGEL SITE via __EXTERNAL LINKS__**
 * __ProfGannon. Wikispaces.com__** **–** this is a wiki space I have on the INTERNET where I have created a spot for **HHP621**
 * IF YOU ARE NOT ALREADY FAMILIAR WITH ANGEL YOU SHOULD LEARN THE FEATURES OF THIS SITE AS SOON AS POSSIBLE. LEARNING HOW TO USE THIS SITE IS A COURSE REQUIREMENT**

server to communicate, **__distribute course material__** and give study hints .This program may be accessed at [|www.canisius.edu] - choose Angel –(**on Quicklink menu**), then sign-on via assigned name and password If you are officially signed up for this course, a link to the **HHP-621 site** shouldl appear. This will allow you to communicate with fellow students and the instructor via **e-mail**, check for announcements, discuss course material, check grades. **__This site should be checked frequently .__ IF YOU ARE NOT ALREADY FAMILIAR WITH THIS SITE YOU SHOULD LEARN THE FEATURES OF THIS SITE AS SOON AS POSSIBLE. LEARNING HOW TO USE THIS SITE IS A COURSE REQUIREMENT.**
 * 'ANGEL'** – We will be using this __course information/platform software__ on the Canisius College

THERE WILL BE NOTES AND SHORT REVIEW TYPE ARTICLES POSTED ON ANGEL/and/or WIKI SITE FOR MOST IF NOT ALL OF THESE TOPICS (**__THESE WILL BE REQUIRED READING__**)
 * Attendance:** Attendance will be recorded for each class. There will be **NO MAKEUP EXAMS**. Make-up EXAMS will only be __considered__ for those who can provide proof of an dire excused absence.
 * If you have any condition which will make it difficult for you to carry out the work as I have outlined it, please notify me in the first week of the course so we may make appropriate arrangement**


 * TENTATIVE SCHEDULE**
 * Please remember we will meet in Health Science Building- Room 221 (second floor)**

presentation -topic selection
==1/28 -**Antianginals – Calcium Channel Blockers** - **Beta Blockers -Nitrates**==

3/4- NO CLASS
==3/11- Antihypertensives -Vasodilators - alpha-adrenoceptor antagonists (alpha-blockers)- angiotensin converting enzyme inhibitors (ACE inhibitors)- angiotensin receptor blockers (ARBs)- calcium-channel blockers - direct acting arterial dilators - ganglionic blockers - nitrodilators- potassium-channel openers==